Our Business
Corporate

We contract manufacture orthopaedic devices and surgical instruments for global multinational companies.

We also commercialize pharmaceuticals, consumer healthcare products and medical devices under the brand of Zynexis in selected ASEAN countries and other international markets.

Corporate

Straits Apex Group

We contract manufacture orthopaedic devices and surgical instruments for global multinational companies.

The orthopaedics business contract manufactures surgical grade orthopaedic devices, components and surgical instruments. Orthopaedic components (e.g. screws, plates, implants, intra-medullary nails, pins, external fixators) are used in the surgical treatment of musculoskeletal disorders resulting from trauma, disease, injuries or deformities.

In 2013, Apex Healthcare Berhad Group made its foray into the business of manufacturing orthopaedics devices for the global market through investment for 40% equity in a new joint venture, ABio Orthopaedics Sdn Bhd. Through further acquisitions, the business was restructured under a 40% owned associate company, Straits Apex Group Sdn Bhd (‘SAG’), which owns two operating 100% subsidiaries, ABio Orthopaedics Sdn Bhd and Straits Orthopaedics (Mfg) Sdn Bhd, through a wholly owned intermediate holding company, Straits Apex Sdn Bhd (‘SA’).

In 2023, SAG divested 60% equity in SA to Quadria Capital, to partially realise value in the business and to position the business for future growth. With a 16% effective equity interest in the SA group of companies through SAG, Apex Healthcare Group is able to participate in the future growth of the orthopaedics business together with Quadria Capital.

For further information, please visit www.straitsortho.com.my

Zynexis

We commercialize pharmaceuticals, consumer healthcare products and medical devices under the brand of Zynexis in selected ASEAN countries and other international markets.

In 2022, Apex Healthcare Group through its wholly-owned Singapore subsidiary, First SGC Pte Ltd entered into a Subscription and Shareholder Agreement with Shanghai Pharmaceutical Import & Export Co., Ltd. a wholly-owned subsidiary of Shanghai Pharmaceuticals Holding Co. Ltd. (‘SPH’) to subscribe SGD 1.2 million (RM 3.9 million) for 40% equity in a Singapore joint venture company which has since been incorporated as Zynexis Healthcare Private Ltd (‘Zynexis’). SPH is a Fortune Global 500 company incorporated in Shanghai, China with dual listings on the stock exchanges in Shanghai and Hong Kong.

Zynexis serves as a vehicle to commercialize pharmaceuticals, consumer healthcare products and medical devices from SPH and AHB Group under the brand of Zynexis in selected ASEAN countries and other international markets. The joint venture with SPH extends Apex Healthcare Group’s capabilities to offer new generation generics as well as leading edge novel and innovative pharmaceutical products to the ASEAN markets

Manufacture

We develop, manufacture and market XEPA branded off-patent generic pharmaceuticals and medical devices. We also conduct contract manufacturing for major pharmaceutical companies.

Manufacture

Learn More →

Distribution

We provide specialist market access services for pharmaceutical companies through provision of regulatory, redressing, sales, marketing and logistics services via a network of 8 distribution facilities in Singapore and Malaysia.

We develop and manage a 2nd portfolio of Group branded pharmaceuticals, consumer healthcare products and medical devices focused on primary care.

Distribution

Learn More →

Corporate

We contract manufacture orthopaedic devices and surgical instruments for global multinational companies.

We also commercialize pharmaceuticals, consumer healthcare products and medical devices under the brand of Zynexis in selected ASEAN countries and other international markets.

About

Our Vision

Through manufacturing and distribution, Apex makes quality pharmaceutical and consumer healthcare products available to our valued customers through our comprehensive supply channels.

Since our establishment in 1962, our business has been focused on making pharmaceutical and consumer healthcare products available to customers in the markets in which we operate, through manufacturing and distribution, and in a manner which fairly rewards all stakeholders. We know our business intimately and have a growing network of loyal customers; this will remain our business for the future. Our confidence in our business stems from a conscious decision to focus resources on our area of expertise, which enables us to increase our capabilities, efficiencies and understanding of underlying trends in the industry.

About

Our Mission

Restoring Health, Enhancing Life.

Apex’s mission is to bring better health and quality of life to all through its businesses. Doctors and Pharmacists use our medicines and diagnostic devices to treat and manage infections, cardiovascular, metabolic, gastroenterological, rheumatic conditions and more. Consumers use our medicated powder and other consumer healthcare products to enhance their wellbeing. We take heart in knowing that our products play a role in the restoration of health and enhancement of life in those who use and trust them.

About

Our Core Values

Service, Quality and Integrity,  Always.

Service is an integral tenet of Apex. From the very first customer in 1962, Apex has striven to provide an efficient, professional and responsive touch in our dealings with suppliers, healthcare professionals, customers and all whom we come across.

The quest to improve Quality is a never-ending journey. We will continually refine our processes and systems in order to secure all commercially relevant global quality certifications.

Integrity is an inescapable part of our business and runs through our value chain from research and development, manufacturing, warehousing, sales and marketing till final delivery. We value honesty in our dealings and there is no compromise.